231 related articles for article (PubMed ID: 17513251)
21. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
22. Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma.
Seishima M; Oda M; Oyama Z; Yoshimura T; Yamazaki F; Aoki T; Nei M; Hashimoto T
Arch Dermatol; 2004 Dec; 140(12):1500-3. PubMed ID: 15611429
[TBL] [Abstract][Full Text] [Related]
23. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris.
Joly P; Thomine E; Gilbert D; Verdier S; Delpech A; Prost C; Lebbe C; Lauret P; Tron F
J Invest Dermatol; 1994 Jul; 103(1):65-72. PubMed ID: 8027582
[TBL] [Abstract][Full Text] [Related]
24. [Paraneoplastic pemphigus].
Descamps V; Belaich S
Presse Med; 1999 Feb; 28(7):363-7. PubMed ID: 10083884
[TBL] [Abstract][Full Text] [Related]
25. Case of paraneoplastic pemphigus with immunoglobulin (Ig)G and IgA antibodies to various antigens.
Otsuka Y; Ueno T; Yamase A; Ito M; Osada S; Kawana S; Funasaka Y; Teye K; Ishii N; Hashimoto T; Saeki H
J Dermatol; 2016 Aug; 43(8):944-6. PubMed ID: 26969813
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus.
Choi Y; Nam KH; Lee JB; Lee JY; Ihm CW; Lee SE; Oh SH; Hashimoto T; Kim SC
J Dermatol; 2012 Dec; 39(12):973-81. PubMed ID: 22938021
[TBL] [Abstract][Full Text] [Related]
27. Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
Plumb R; Doolittle GC
Am J Hematol; 1996 May; 52(1):58-9. PubMed ID: 8638613
[TBL] [Abstract][Full Text] [Related]
28. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus.
Wang J; Bu DF; Li T; Zheng R; Zhang BX; Chen XX; Zhu XJ
Br J Dermatol; 2005 Sep; 153(3):558-64. PubMed ID: 16120143
[TBL] [Abstract][Full Text] [Related]
29. Envoplakin and periplakin are the paraneoplastic pemphigus antigens.
Kiyokawa C
Kurume Med J; 1999; 46(1):71-8. PubMed ID: 10319615
[TBL] [Abstract][Full Text] [Related]
30. Clinical and immunopathological spectrum of paraneoplastic pemphigus.
Zimmermann J; Bahmer F; Rose C; Zillikens D; Schmidt E
J Dtsch Dermatol Ges; 2010 Aug; 8(8):598-606. PubMed ID: 20180886
[TBL] [Abstract][Full Text] [Related]
31. [Paraneoplastic pemphigus: review of the literature, apropos of a case associated with chronic lymphoid leukemia].
Rodot S; Botcazou V; Lacour JP; Dor JF; Bodokh I; Joly P; Ortonne JP
Rev Med Interne; 1995; 16(12):938-43. PubMed ID: 8570960
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic pemphigus in association with B-cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone.
Nanda M; Nanda A; Al-Sabah H; Dvorak R; Alsaleh QA
Int J Dermatol; 2007 Jul; 46(7):767-9. PubMed ID: 17614814
[No Abstract] [Full Text] [Related]
33. Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment.
Kartan S; Shi VY; Clark AK; Chan LS
Am J Clin Dermatol; 2017 Feb; 18(1):105-126. PubMed ID: 27878477
[TBL] [Abstract][Full Text] [Related]
34. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.
Nguyen VT; Ndoye A; Bassler KD; Shultz LD; Shields MC; Ruben BS; Webber RJ; Pittelkow MR; Lynch PJ; Grando SA
Arch Dermatol; 2001 Feb; 137(2):193-206. PubMed ID: 11176692
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab.
Meijs M; Mekkes J; van Noesel C; Nijhuis E; Leeksma O; Jonkman M; Hoekzema R
Int J Dermatol; 2008 Jun; 47(6):632-4. PubMed ID: 18477166
[No Abstract] [Full Text] [Related]
36. Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus.
Huang Y; Li J; Zhu X
Arch Dermatol Res; 2009 Oct; 301(10):703-9. PubMed ID: 18820940
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of pemphigus.
Tsuruta D; Ishii N; Hashimoto T
Immunotherapy; 2012 Jul; 4(7):735-45. PubMed ID: 22853759
[TBL] [Abstract][Full Text] [Related]
38. Paraneoplastic pemphigus: a short review.
Wieczorek M; Czernik A
Clin Cosmet Investig Dermatol; 2016; 9():291-295. PubMed ID: 27729809
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy.
Paolino G; Didona D; Magliulo G; Iannella G; Didona B; Mercuri SR; Moliterni E; Donati M; Ciofalo A; Granata G; Ranuzzi P; Falasca V; Calvieri S
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186863
[TBL] [Abstract][Full Text] [Related]
40. Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities.
Rossum MM; Verhaegen NT; Jonkman MF; Mackenzie MA; Koster A; Van Der Valk PG; Span LF
Leuk Lymphoma; 2004 Nov; 45(11):2327-32. PubMed ID: 15512825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
